IN8bio

INAB • NASDAQ • Stock Fundamentals

IN8bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Tai-Wei, with a market cap of $13.8M.

Market Cap$13.8M

Employees34.0

CEOTai-Wei

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about IN8bio

IN8bio (INAB) has a market capitalization of $13.8M and trades on NASDAQ.

IN8bio has approximately 34 employees.